Share your vision about scientist 2030

futuristic loop

The recognition and appreciation of the scientist of the future will be the subject of our discussion with established and young scientists, researchers, funding organisations and civil-society partners.


ZonMw joines GLoPID-R for infectious diseases

GloPID-R is pleased to welcome the Netherlands Organisation for Health Research and Development (ZonMw), represented by Suzanne Verver, into the network. GloPID-R is a unique international network of major research funding organizations. The network of 27 countries facilitates a rapid and effective research response to infectious disease outbreaks.


ZonMw, NWO and KNAW to sign DORA declaration

KNAW (Royal Netherlands Academy of Arts and Sciences), NWO (Netherlands Organisation for Scientific Research) and ZonMw (Netherlands Organisation for Health Research and Development) will sign the San Francisco Declaration on Research Assessment (DORA) on 18 April.


ZonMw participates in the public-private partnership VALUE-Dx to fight antimicrobial resistance

On April 1st 2019 the kick-off meeting of the European public-private partnership VALUE-Dx took place. This European-wide approach aims to generate evidence on the medical, economic, and public health value of diagnostics in tackling antimicrobial resistance (AMR). As a member of the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR), ZonMw participates in this consortium.


Young research talents off to foreign top institutes thanks to Rubicon

17 researchers who have recently received their PhDs can do their research at foreign research institutes thanks to a Rubicon grant from NWO. They will investigate, amongst other things, artificial intelligence for improved ultrasonography, Imaging muscle function in ALS patients, Printing living tissue through protective cell coating and new blood vessel formation.



Preventing behavioural problems from changing the child's brain

Research conducted at Erasmus University Rotterdam reveals that a child's brain changes in the event of persistent behavioural problems. Windesheim University of Applied Sciences translates this type of new knowledge into the educational situation.


From fundamental research to personalised medicine for cancer: ‘We increasingly know which drug works best for which patient.'

Fundamental research formed the basis for the personalised treatment of cancer patients. Thanks to whole gene sequencing, doctors can now treat their patients based on their genetic makeup. That is not only good news for the patient but also medical science, says Edwin Cuppen, director of the Hartwig Medical Foundation. ‘Knowledge about cancer is increasing, and much of that is entering the clinic to improve the treatment of patients’.


Gender in research fellowship

This Summer, ZonMw and Erasmus MC offer an interesting joint course program on gender, health and research, as part of the Erasmus Summer Programme in Rotterdam, The Netherlands. The Gender and Health Knowledge Program offers 20 Gender in Research Fellowships for PhD-students and post-doctoral researchers to participate in the program.


SAVE THE DATE: Evolution or revolution?

Join the discussion about the scientist of 2030. Is it time for a scientific revolution? Society is increasingly critical about the value and function of science. Scientists are heavily dependent on citations and 'impact factors' for recognition of their work, and they feel under huge pressure to perform and publish while at the same time juggling their other academic responsibilities.


32 scientists to receive NWO Vici grants worth 1.5 million euros 32 leading scientists will each receive 1.5 million

32 leading scientists will each receive 1.5 million euros from the Netherlands Organisation for Scientific Research (NWO). This Vici grant will enable them to develop an innovative line of research and set up their own research group in the coming five years. Vici is one of the largest scientific grants for individuals in the Netherlands and targets advanced researchers.

To top
Direct naar: InhoudSkip to navigationSkip to website footer